Frazier Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.4K Sell
106
-21
-17% -$10.1K 0.03% 179
2026
Q1
$62.7K Buy
127
+45
+55% +$24.4K 0.03% 161
2025
Q4
$47.5K Sell
82
-25
-23% -$14.1K 0.03% 169
2025
Q3
$51.9K Buy
107
+25
+30% +$11.6K 0.03% 153
2025
Q2
$33.3K Hold
82
0.02% 196
2025
Q1
$40.8K Hold
82
0.03% 156
2024
Q4
$42.6K Sell
82
-2
-2% -$1.1K 0.03% 150
2024
Q3
$52K Sell
84
-17
-17% -$10.1K 0.04% 138
2024
Q2
$55.9K Sell
101
-1
-1% -$573 0.04% 134
2024
Q1
$59.3K Buy
102
+9
+10% +$5.05K 0.05% 136
2023
Q4
$49.4K Buy
+93
New +$45K 0.04% 139

Other funds holding TMO

Frazier Financial Advisors's TMO Position: Q2 2026 in Review

Frazier Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, selling an estimated $10.1K and leaving 106 shares worth $53.4K. The position accounts for 0.03% of the portfolio, ranked #179.

Frazier Financial Advisors first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $62.7K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Frazier Financial Advisors held 106 shares of Thermo Fisher Scientific worth $53.4K as of Q2 2026.
  • Frazier Financial Advisors sold 21 Thermo Fisher Scientific shares in Q2 2026, an estimated $10.1K.
  • Thermo Fisher Scientific made up 0.03% of Frazier Financial Advisors's portfolio in Q2 2026, its #179 holding.
  • Frazier Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Frazier Financial Advisors's Thermo Fisher Scientific position peaked at $62.7K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.